Chronic Hepatics C Virus (HCV) Genotype 1 (DBCOND0111148)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04155515	A Phase III Study to Evaluate Efficacy and Safety of TG-2349 in Combination With DAG181 and RBV for HCV Type I Patients	Furaprevir Ribavirin Yimitasvir	treatment	3	completed
NCT03593447	To Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected Patients	Furaprevir Ribavirin Yimitasvir	treatment	2	completed